移动站  | 2017年11月24日 星期五
用户登录

当前位置:首页 >> 师资队伍

基本信息:

姓名: 黄学锋
职务: 肛肠外科主任
职称: 主任医师
学历: 硕士研究生
专业: 肛肠外科
所属院系: 邵氏医院
研究方向: 结直肠癌基础与临床
电话: 86002141
信箱: srrsh77@yahoo.com
个人主页:

个人简介:

教育:
1988年毕业于浙江医科大学,获学士学位;
1993年获得肿瘤学硕士学位。毕业后一直从事结直肠肿瘤的基础与临床治疗的研究;
2001.3—2002.7在美国MD Anderson癌症中心从事肿瘤治疗相关的基因治疗研究;
2008.04—2008.05 在Mayo Clinic结直肠肛门外科学习;

工作:
1988.08-2003.09 浙江大学医学院附属第一医院;
2003.09-今 浙江大学医学院附属邵逸夫医院;

学术兼职:
中国抗癌协会大肠癌专业委员会青年委员;
中国中西医结合大肠肛门病专业委员会委员;
浙江省医师协会肛肠科医师分会副会长;
浙江省医学会肛肠外科分会委员;
浙江省中西医结合学会大肠肛门病专业委员会委员;

发表论文
1. Huang X, Lin T, Gu J, Zhang L, Roth JA, Stephens LC, Yu Y, Liu J, Fang B. Combined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograft. Gene Ther. 2002 Oct;9(20):1379-86.
2. Huang X, Lin T, Gu J, Zhang L, Roth JA, Liu J, Fang B. Cell to cell contact required for bystander effect of the TNF-related apoptosis-inducing ligand (TRAIL) gene. Int J Oncol. 2003 Jun;22(6):1241-5.
3. Lin T, Huang X, Gu J, Zhang L, Roth JA, Xiong M, Curley SA, Yu Y, Hunt KK, Fang B. Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells. Oncogene. 2002 Nov 14;21(52):8020-8.
4. Zhu H, Zhang L, Huang X, Davis JJ, Jacob DA, Teraishi F, Chiao P, Fang B. Overcoming acquired resistance to TRAIL by chemotherapeutic agents and calpain inhibitor I through distinct mechanisms. Mol Ther. 2004 May;9(5):666-73.
5. Lin T, Gu J, Zhang L, Huang X, Stephens LC, Curley SA, Fang B. Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes. Cancer Res. 2002 Jul 1;62(13):3620-5.
6. Gu J, Zhang L, Huang X, Lin T, Yin M, Xu K, Ji L, Roth JA, Fang B. A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo. Oncogene. 2002 Jul 18;21(31):4757-64.
7. Zhang L, Gu J, Lin T, Huang X, Roth JA, Fang B. Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line. Gene Ther. 2002 Sep;9(18):1262-70.
8. Lin T, Gu J, Zhang L, Davis JJ, Huang X, Cabbini G, Ji L, Fang B. Enhancing adenovirus-mediated gene transfer in vitro and in vivo by addition of protamine and hydrocortisone. J Gene Med. 2003 Oct;5(10):868-75.